Phase II/III (Integrated)

392 trials 186 recruiting

Filter these 392 trials by condition, country, sponsor and more.

Open in Search →

A multicentric, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of COLIRIOBCN070660 administered topically in pa… Recruiting

2023-505791-30-01 Diabetic Retinopathy 2024-04-17
Peritoneal Ultrafiltration in Cardio Renal Syndrome to Prevent Heart Failure Exacerbation (PURE) Recruiting

2024-512658-41-00 Congestive Heart Failure 2024-03-06
A phase 2 trial in stage II-IIIa urothelial cancer randomizing pre-operative nivolumab with or without relatlimab - TURANDORELA Recruiting

2023-507460-39-00 Adult patients with resectable muscle-invasive urotheli 2024-02-15
Alpelisib for the treatment of lymphatic malformations associated with a PIK3CA mutation Recruiting

2023-504146-60-00 lymphatic malformations associated with PIK3CA mutation 2024-02-07
Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease an… Recruiting

2023-506508-18-00 Parkinson's disease 2024-01-19
Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULC… Recruiting

2022-502685-25-00 The trial population will consist of patients with LAVC 2024-01-01
Imaging multiple myeloma patients in the REMNANT study with Fluciclovine PET/CT (FLUCIPET) Recruiting

2024-517095-38-00 multiple myeloma 2023-12-18
Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute Recruiting

2022-502974-18-00 C. spp. prosthetic joint infection 2023-11-27
Open-label, prospective study evaluating the efficacy and safety of Tirbanibulin 1% (Klisyri®) in the treatment of superficial basal cell ca… Recruiting

2023-505971-66-00 Superficial Basal cell carcinoma 2023-11-17
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate… Recruiting

2023-503295-25-00 Resectable biliary tract cancers 2023-10-31
Adaptative, multicenter, randomized, double-blind, parallel-group, placebo controlled, clinical trial, on the efficacy and tolerability of d… Recruiting

2024-511961-12-00 Knee osteoarthritis 2023-10-12
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Recruiting

2024-518844-20-00 Treatment of Acute Gout Flare 2023-10-03
Efficacy of melatonin, low-dose quetiapine, or placebo in patients with psychiatric disorders and comorbid insomnia: a randomized clinical t… Recruiting

2023-504728-24-00 Psychiatric disorder (ICD-10 F20-F69, F84, F90-F95) and 2023-09-15
Tebentafusp Regimen Versus Investigator’s Choice in Previously Treated Advanced Melanoma (TEBE-AM) Recruiting

2022-502732-39-00 Previously treated non-ocular advanced melanoma 2023-09-01
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX- 880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaire… Recruiting

2024-513929-23-00 Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awa 2023-05-26
A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericigua… Recruiting

2022-501238-52-00 Heart failure due to systemic left ventricular systolic 2023-03-23
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN). Recruiting

2023-507233-19-00 Treatment of IgAN 2023-02-16
A Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cut… Recruiting

2023-505634-94-00 Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneo 2023-02-02
EvER-ILD 2: Evaluation of Efficacy and safety of Rituximab in patients with progressive Interstitial Lung Disease (ILD) with inflammatory co… Recruiting

2022-501335-16-00 Interstitial lung disease 2023-01-16
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neu… Recruiting

2024-510990-21-00 Mucopolysaccharidosis Type II [MPS II] 2022-11-11
Phase 2/3 Adaptive Study of VX-147 in Adults and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease Recruiting

2024-515633-15-00 APOL1-mediated Proteinuric Kidney Disease (AMKD) 2022-10-25
An Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Activity of Nipocalimab in Child… Recruiting

2022-502539-21-00 Myasthenia gravis (MG) 2022-10-21
Phase II Dutasteride in combination with CAB vs CAB in SDC (DUCT) Recruiting

2022-500745-24-00 Salivary Duct Carcinoma 2022-09-20
“A Phase II, double-blinded, placebo-controlled clinical trial to evaluate the safety and efficacy of mesenchymal cells (MSV-ALLO®) in the t… Recruiting

2024-514750-67-00 Lupus Nephritis 2022-09-13